VACN Stock Analysis: VAT | SW
Specialty Industrial Machinery | SW, Switzerland | Market Cap: 19.341m CHF | 12M Return: 124.7% | CH0311864901 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 38.6M
Warnings
Tailwinds
Seasonality 10.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
VAT Group AG, founded in 1965 and headquartered in Solothurn, Switzerland, develops, manufactures, and sells vacuum valves, multi-valve modules, motion components, and edge-welded metal bellows. The company operates through two segments: Valves, which supplies vacuum valves to the semiconductor, display, photovoltaic, and vacuum coating industries as well as industrial and research customers, and Global Service, which provides spare parts, repairs, upgrades, and support. Its product range spans isolation, gate, angle, inline, check, cylinder, all-metal, pendulum, butterfly, control, transfer, and pressure-relief valves, along with flange connections, bellows, and modules.
Vacuum valves are mission-critical components in semiconductor wafer fabrication equipment, where contamination control directly affects chip yield. The industry is characterized by high entry barriers due to precision engineering requirements and long qualification cycles with equipment manufacturers, supporting a concentrated supplier landscape in which VAT holds a leading position.
The Global Service segment provides recurring aftermarket revenue tied to the installed base of valves, which typically require periodic maintenance and replacement. VAT operates globally, with direct presence across Switzerland, the rest of Europe, the United States, Japan, Korea, Singapore, China, and additional Asian markets, reflecting the geographic concentration of semiconductor and display manufacturing in East Asia.
- Semiconductor wafer fab equipment spending drives valve demand
- Global Service segment expands as installed base grows
- AI and advanced node capacity buildout boosts order pipeline
| Net Income: 207.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 1.09 > 1.0 |
| NWC/Revenue: 32.67% < 20% (prev 18.29%; Δ 14.38% < -1%) |
| CFO/TA 0.19 > 3% & CFO 266.1m > Net Income 207.5m |
| Net Debt (281.6m) to EBITDA (300.8m): 0.94 < 3 |
| Current Ratio: 2.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.9m) vs 12m ago -0.31% < -2% |
| Gross Margin: 18.57% > 18% (prev 52.15%; Δ -33.58% > 0.5%) |
| Asset Turnover: 75.30% > 50% (prev 77.39%; Δ -2.09% > 0%) |
| Interest Coverage Ratio: 127.3 > 6 (EBIT TTM 248.9m / Interest Expense TTM 1.96m) |
| A: 0.24 (Total Current Assets 579.4m - Total Current Liabilities 243.7m) / Total Assets 1.37b |
| B: 0.52 (Retained Earnings 713.7m / Total Assets 1.37b) |
| C: 0.18 (EBIT TTM 248.9m / Avg Total Assets 1.36b) |
| D: 1.00 (Book Value of Equity 685.0m / Total Liabilities 686.5m) |
| Altman-Z'' = 5.58 = AAA |
| DSRI: 1.08 (Receivables 178.0m/168.3m, Revenue 1.03b/1.05b) |
| GMI: 2.81 (GM 52.15% / 18.57%) |
| AQI: 0.98 (AQ_t 0.33 / AQ_t-1 0.34) |
| SGI: 0.98 (Revenue 1.03b / 1.05b) |
| TATA: -0.04 (NI 207.5m - CFO 266.1m) / TA 1.37b) |
| Beneish M = -1.35 (Cap -4..+1) = D |
As of August 24, 2026, the stock is trading at CHF 604.60 with a total of 59,341 shares traded. Over the past week, the price has changed by -6.32%, over one month by -6.64%, over three months by -1.98% and over the past year by +124.67%.
Current recommended Stop Loss: 562.50 (which is 7% or 1.8 ATR below the current price).
VAT has no consensus analysts rating.
P/E Trailing = 93.4009
P/E Forward = 61.3497
P/S = 18.824
P/B = 27.3875
P/EG = 3.1588
Revenue TTM = 1.03b CHF
EBIT TTM = 248.9m CHF
EBITDA TTM = 300.8m CHF
Long Term Debt = 44.7m CHF (from longTermDebt, last fiscal year)
Short Term Debt = 3.85m CHF (from shortTermDebt, last quarter)
Debt = 396.9m CHF (from shortLongTermDebtTotal, last quarter)
Net Debt = 281.6m CHF (calculated: Debt 396.9m - CCE 115.3m)
Enterprise Value = 19.6b CHF (19.3b + Debt 396.9m - CCE 115.3m)
Interest Coverage Ratio = 127.3 (Ebit TTM 248.9m / Interest Expense TTM 1.96m)
EV/FCF = 83.91x (Enterprise Value 19.6b / FCF TTM 233.9m)
FCF Yield = 1.19% (FCF TTM 233.9m / Enterprise Value 19.6b)
FCF Margin = 22.76% (FCF TTM 233.9m / Revenue TTM 1.03b)
Net Margin = 20.20% (Net Income TTM 207.5m / Revenue TTM 1.03b)
Gross Margin = 18.57% ((Revenue TTM 1.03b - Cost of Revenue TTM 836.7m) / Revenue TTM)
Gross Margin QoQ = 34.24% (prev 3.00%)
Tobins Q-Ratio = 14.31 (Enterprise Value 19.6b / Total Assets 1.37b)
Interest Expense / Debt = 0.49% (Interest Expense 1.96m / Debt 396.9m)
Taxrate = 15.98% (39.5m / 247.0m)
NOPAT = 209.1m (EBIT 248.9m * (1 - 15.98%))
Current Ratio = 2.38 (Total Current Assets 579.4m / Total Current Liabilities 243.7m)
Debt / Equity = 0.58 (Debt 396.9m / totalStockholderEquity, last quarter 685.0m)
Debt / EBITDA = 0.94 (Net Debt 281.6m / EBITDA 300.8m)
Debt / FCF = 1.20 (Net Debt 281.6m / FCF TTM 233.9m)
Total Stockholder Equity = 731.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.21% (Net Income 207.5m / Total Assets 1.37b)
RoE = 28.37% (Net Income TTM 207.5m / Total Stockholder Equity 731.6m)
RoCE = 32.07% (EBIT 248.9m / Capital Employed (Equity 731.6m + L.T.Debt 44.7m))
RoIC = 19.36% (NOPAT 209.1m / Invested Capital 1.08b)
WACC = 10.57% (E(19.3b)/V(19.7b) * Re(10.78%) + D(396.9m)/V(19.7b) * Rd(0.49%) * (1-Tc(0.16)))
Discount Rate = 10.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -69.04 | Cagr: -0.11%
[DCF] Terminal Value 69.25% ; FCFF base≈227.0m ; Y1≈242.9m ; Y5≈292.1m
[DCF] Fair Price = 98.74 (EV 3.24b - Net Debt 281.6m = Equity 2.96b / Shares 30.0m; r=10.57% [WACC]; 5y FCF grow 7.91% → 2.50% )
EPS Correlation: 67.58 | EPS CAGR: 48.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 88.30 | Revenue CAGR: 8.61% | SUE: 1.85 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=10.61 | Chg30d=+3.32% | Revisions=+69% | GrowthEPS=+48.5% | GrowthRev=+23.8%
EPS next Year (2027-12-31): EPS=16.82 | Chg30d=+13.52% | Revisions=+81% | GrowthEPS=+58.5% | GrowthRev=+39.9%
[Analyst] Revisions Ratio: +83% (up=25, down=1)